PTGER2 and status epilepticus: Our finding that ECs downregulate prostaglandin receptor 2 (EP2) expression in PCs, together with the fact that COX-2 derived prostaglandins disrupt BBB and EP2 receptor blockers reduce delayed mortality and brain inflammation in status epilepticus [80], suggests that under basal conditions ECs upregulate anti-inflammatory mechanisms capable to disrupting BBB.